83 related articles for article (PubMed ID: 11896464)
1. Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.
Arafat WO; Gómez-Navarro J; Buchsbaum DJ; Xiang J; Wang M; Casado E; Barker SD; Mahasreshti PJ; Haisma HJ; Barnes MN; Siegal GP; Alvarez RD; Hemminki A; Nettelbeck DM; Curiel DT
Gene Ther; 2002 Feb; 9(4):256-62. PubMed ID: 11896464
[TBL] [Abstract][Full Text] [Related]
2. Targeting of adenoviral vectors through a bispecific single-chain antibody.
Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
[TBL] [Abstract][Full Text] [Related]
3. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
Li X; Stuckert P; Bosch I; Marks JD; Marasco WA
Cancer Gene Ther; 2001 Aug; 8(8):555-65. PubMed ID: 11571533
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
Rosenfeld ME; Rogers BE; Khazaeli MB; Mikheeva G; Raben D; Mayo MS; Curiel DT; Buchsbaum DJ
Clin Cancer Res; 1997 Jul; 3(7):1187-94. PubMed ID: 9815798
[TBL] [Abstract][Full Text] [Related]
5. Targeted tumor killing via an intracellular antibody against erbB-2.
Deshane J; Siegal GP; Alvarez RD; Wang MH; Feng M; Cabrera G; Liu T; Kay M; Curiel DT
J Clin Invest; 1995 Dec; 96(6):2980-9. PubMed ID: 8675670
[TBL] [Abstract][Full Text] [Related]
6. Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.
Afanasieva TA; Wittmer M; Vitaliti A; Ajmo M; Neri D; Klemenz R
Gene Ther; 2003 Oct; 10(21):1850-9. PubMed ID: 12960975
[TBL] [Abstract][Full Text] [Related]
7. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
9. Codon optimization, expression, and characterization of an internalizing anti-ErbB2 single-chain antibody in Pichia pastoris.
Hu S; Li L; Qiao J; Guo Y; Cheng L; Liu J
Protein Expr Purif; 2006 May; 47(1):249-57. PubMed ID: 16403645
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target.
Arafat W; Gómez-Navarro J; Xiang J; Siegal GP; Alvarez RD; Curiel DT
Cancer Gene Ther; 2000 Sep; 7(9):1250-6. PubMed ID: 11023197
[TBL] [Abstract][Full Text] [Related]
11. An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery.
Hedley SJ; Auf der Maur A; Hohn S; Escher D; Barberis A; Glasgow JN; Douglas JT; Korokhov N; Curiel DT
Gene Ther; 2006 Jan; 13(1):88-94. PubMed ID: 16107860
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins.
Whittington HA; Ashworth LJ; Hawkins RE
Gene Ther; 1998 Jun; 5(6):770-7. PubMed ID: 9747457
[TBL] [Abstract][Full Text] [Related]
13. [Expression and Characterization of Single-chain Fv-Fc Fusion Protein against Human P185(erbB2)].
Xie ZG; Guo N; Shi M; Feng JN; Yu M; Sun YX; Shen BF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):371-4. PubMed ID: 12673393
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
[TBL] [Abstract][Full Text] [Related]
15. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
16. Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.
Deshane J; Siegal GP; Wang M; Wright M; Bucy RP; Alvarez RD; Curiel DT
Gynecol Oncol; 1997 Mar; 64(3):378-85. PubMed ID: 9062138
[TBL] [Abstract][Full Text] [Related]
17. Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo.
Shi M; Zhang L; Gu HT; Jiang FQ; Qian L; Yu M; Chen GJ; Luo Q; Shen BF; Guo N
Acta Pharmacol Sin; 2007 Oct; 28(10):1611-20. PubMed ID: 17883948
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
[TBL] [Abstract][Full Text] [Related]
19. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
[TBL] [Abstract][Full Text] [Related]
20. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
